NEW YORK, November 24, 2016 /PRNewswire/ -- The global peripherally inserted central catheters market is dominated by few key players such as Teleflex Incorporated, AngioDynamics Inc., C.R. Bard Inc., Vygon S.A, and Cook Medical Inc. and together, these companies constitute around 80%-85% of the overall market share Persistence Market Research delivers key insights on the global peripherally inserted central catheters market in its upcoming report titled "Global Market Study on Peripherally Inserted Central Catheters: Power Injected Peripherally Inserted Central Catheters Product Type Segment to Dominate the Market Through 2024. "The global peripherally inserted central catheters market is anticipated to reach a market valuation of US$ 673.9 Mn by the end of 2016. In terms of revenue, the global peripherally inserted central catheters market is projected to register a healthy CAGR of 5.8% over the forecast period (2016 - 2024) owing to various factors, regarding which Persistence Market Research offers vital insights in detail. (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO )Increasing healthcare expenditure, robust reimbursement policies, increasing preference for peripherally inserted central catheters by healthcare physicians, and increasing number of diseases requiring the application of peripherally inserted central catheters are some of the factors likely to boost the growth of the global peripherally inserted central catheters market over the forecast period. View Report Overview and Research Methodology @http://www.persistencemarketresearch.com/market-research/peripherally-inserted-central-catheters-market.asp The Power Injected Peripherally Inserted Central Catheters product type segment dominated the global peripherally inserted central catheters market in revenue terms, accounting for 82.2% value share in 2015 and is expected to continue to do so throughout the forecast period. This segment is expected to grow with a healthy CAGR over the forecast period, owing to high adoption rate of newly launched products and better reimbursement policies. The Multiple Lumen design segment is anticipated to account for 59.7% revenue share of the global peripherally inserted central catheters market by 2016 end. This segment is expected to expand at a CAGR of 6.7% over the forecast period due to increase in the number of cancer patients requiring multiple lumen peripherally inserted central catheters for better treatment. The Hospitals end user segment accounted for 68.3% value share in 2015 and is projected to account for 72.0% share by 2024 end.